Detalhe da pesquisa
1.
Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient.
Cell
; 170(5): 927-938.e20, 2017 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-28841418
2.
Ovarian cancer mutational processes drive site-specific immune evasion.
Nature
; 612(7941): 778-786, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36517593
3.
Trends in specific procedures performed at the time of cytoreduction for ovarian cancer: Is interval debulking surgery truly less radical? A Memorial Sloan Kettering Cancer Center Team Ovary study.
Gynecol Oncol
; 187: 80-84, 2024 May 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38735143
4.
Secondary cytoreductive surgery and oncologic outcomes in the era of targeted maintenance therapy for recurrent, platinum-sensitive ovarian cancer.
Gynecol Oncol
; 186: 104-109, 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38640773
5.
Mesonephric and mesonephric-like adenocarcinomas of gynecologic origin: A single-center experience with molecular characterization, treatment, and oncologic outcomes.
Gynecol Oncol
; 182: 32-38, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38246044
6.
Regionalizing ovarian cancer cytoreduction to high-volume centers and the impact on patient travel in New York State.
Gynecol Oncol
; 182: 141-147, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38262237
7.
ARIA II: a randomized controlled trial of near-infrared Angiography during RectosIgmoid resection and Anastomosis in women with ovarian cancer.
Int J Gynecol Cancer
; 2024 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38514101
8.
Procedural interventions for oligoprogression during treatment with immune checkpoint blockade in gynecologic malignancies: a case series.
Int J Gynecol Cancer
; 34(4): 594-601, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38296517
9.
Chemotherapy response in low-grade serous ovarian carcinoma at a comprehensive cancer center: Readdressing the roles of platinum and cytotoxic therapies.
Cancer
; 129(13): 2004-2012, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36951509
10.
The 2022 PSOGI International Consensus on HIPEC Regimens for Peritoneal Malignancies: Epithelial Ovarian Cancer.
Ann Surg Oncol
; 30(13): 8115-8137, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37561343
11.
Oncologic outcomes of robot-assisted laparoscopy versus conventional laparoscopy for the treatment of apparent early-stage endometrioid adenocarcinoma of the uterus.
Gynecol Oncol
; 179: 152-157, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37980770
12.
Outcomes and long-term follow-up by treatment type for patients with advanced-stage ovarian cancer managed at a tertiary cancer center: A Memorial Sloan Kettering Cancer Center Team Ovary study.
Gynecol Oncol
; 169: 118-124, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36565685
13.
Sentinel lymph node mapping in patients with endometrial hyperplasia: A practice to preserve or abandon?
Gynecol Oncol
; 168: 1-7, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36334496
14.
Impact of postoperative morbidity on outcomes in patients with advanced epithelial ovarian cancer undergoing intestinal surgery at the time of primary or interval cytoreductive surgery: A Memorial Sloan Kettering Cancer Center Team Ovary study.
Gynecol Oncol
; 179: 169-179, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37992548
15.
Intrathoracic surgery as part of primary cytoreduction for advanced ovarian cancer: Going to the next level - A Memorial Sloan Kettering Cancer Center study.
Gynecol Oncol
; 170: 46-53, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36621269
16.
Predicting outcomes in female germ cell tumors using a modified International Germ Cell Cancer Collaborative Group classification system to guide management.
Gynecol Oncol
; 170: 93-101, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36669327
17.
Ten-year conditional probability of survival for patients with ovarian cancer: A new metric tailored to Long-term survivors.
Gynecol Oncol
; 169: 85-90, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36521353
18.
Association of bowel preparation with surgical-site infection in gynecologic oncology surgery: Post-hoc analysis of a randomized controlled trial.
Gynecol Oncol
; 168: 100-106, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36423444
19.
Morbidity after secondary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for ovarian cancer: An analysis of a randomized phase II trial.
Gynecol Oncol
; 171: 23-30, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36804618
20.
Patient-reported symptoms after minimally invasive hysterectomy and association with postoperative complications.
Gynecol Oncol
; 175: 163-168, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37390597